Home > Cashflow Statement > BETA DRUGS

BETA DRUGS
Cash Flow from Financing Activities

    Back to Cashflow Statement
BETA DRUGS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BETA DRUGS
Please provide your vote to see the results

BETA DRUGS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Cash Flow from Financing Activities ₹-8.07 Cr₹118 Cr₹-7.49 Cr₹-2.47 Cr₹-0.97 Cr

What is the latest Cash Flow from Financing Activities ratio of BETA DRUGS ?

The latest Cash Flow from Financing Activities ratio of BETA DRUGS is ₹-8.07 Cr based on Mar2026 Consolidated results.
Year Cash Flow from Financing Activities
Mar2026₹-8.07 Cr
Mar2025₹118 Cr
Mar2024₹-7.49 Cr
Mar2023₹-2.47 Cr
Mar2022₹-0.97 Cr

How is Cash Flow from Financing Activities of BETA DRUGS Trending?

Years Cash Flow from Financing Activities % Change
Mar2026 ₹-8.07 Cr
Negative
Mar2025 ₹118 Cr
Positive
Mar2024 ₹-7.49 Cr
Negative
Mar2023 ₹-2.47 Cr
Negative
Mar2022 ₹-0.97 Cr -

Compare Cash Flow from Financing Activities of peers of BETA DRUGS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BETA DRUGS ₹1,989.7 Cr -4.2% 0.5% 8.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,688.0 Cr -1.4% 6.3% 7.8% Stock Analytics
DIVIS LABORATORIES ₹295,080.0 Cr -1.8% 20.6% 70.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹177,677.0 Cr -1.9% 2.4% 22.7% Stock Analytics
DR REDDYS LABORATORIES ₹115,852.0 Cr 0.8% 12.6% 12.3% Stock Analytics
CIPLA ₹111,731.0 Cr -2.4% 4.4% -8.3% Stock Analytics


BETA DRUGS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BETA DRUGS

-4.2%

0.5%

8.3%

SENSEX

1.8%

11.1%

-1.6%


You may also like the below Video Courses